Our Policy Proposals for Reducing Health Care Costs The NHC released new recommendations in Sept. 2021. Read them here. The National Health Council (NHC) envisions a society in which all […]
Additional Resources
Patient Perspectives on Real-World Evidence: Enhancing Engagement, Understanding, and Trust
Patient Perspectives on Real-World Evidence: A Roundtable to Gather Views, Needs, and Recommendations The topic of real-world evidence (RWE) has gained considerable attention recently. As health researchers, policymakers, and regulators […]
Tools to Support Sponsor-Patient Engagement: Fair-Market-Value Calculator and Engagement Templates
Sponsor-Patient Engagement Toolbox Eleanor Perfetto, PhD, MS, Executive Vice President of Strategic Initiatives, and Silke Schoch, Manager, Research & Programs, will present the NHC’s Patient Engagement Fair Market Value (FMV) […]
The National Health Council Rubric to Capture the Patient Voice: A Guide to Incorporating the Patient Voice into the Health Ecosystem
The National Health Council Rubric to Capture the Patient Voice: A Guide to Incorporating the Patient Voice into the Health Ecosystem The purpose of the National Health Council (NHC) Rubric […]
Improving the Use of Patient-Provided Information in Real-World Evidence Research
Improving the Use of Patient-Provided Information in Real-World Evidence Research Study Objective To understand how patient-provided information (PPI) – gathered through meaningful patient engagement – can be translated by researchers […]
Patient-Focused Medical Product Case Examples
Patient-Focused Medical Product Development Case Examples About Patient-Focused Medical Product Development Patient-focused medical product development is a mechanism by which stakeholders, including but not limited to medical product developers, academics, […]
Glossary of Patient Engagement Terms
The definitions of these terms, which includes Family Caregiver, Meaningful Engagement, and Patient-Focused Drug Development, stem largely from our patient engagement work, including our ‘Patient-Focused Drug Development – Recommended Language […]